Additionally, the profiles from TCGA database also showed that high INSL5 expression was correlated with poor overall survival in multiple tumors, especially in glioma, kidney renal clear cell carcinoma, sarcoma, uterine carcinosarcoma, and uveal melanoma patients (Fig EV1E–I). Here, INSL5 is linked to central nervous system cancer.